Skip to content

Drug interactions

Ergotamine + Lemborexant

Severity: Minor

Ergotamine and Lemborexant: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ergotamine is not a recognized CYP3A4 inhibitor, so any increase in lemborexant exposure is likely small and unproven. If it occurs, it could increase somnolence and next-day impairment.

What this interaction means in plain words

Ergotamine and Lemborexant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ergotamine belongs to Central Nervous System; Lemborexant belongs to Central Nervous System.

Evidence level: Low

Why it happens

Theoretical weak competition for CYP3A4 metabolism of lemborexant.

What to do

Monitor for excessive sedation and next-day drowsiness. Reduce the lemborexant dose if impairment occurs.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ergotamine and Lemborexant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ergotamine with Lemborexant?

MediHelp rates the interaction as minor. Ergotamine and Lemborexant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ergotamine is not a recognized CYP3A4 inhibitor, so any increase in lemborexant exposure is likely small and unproven. If it occurs, it could increase somnolence and next-day impairment.

How serious is the interaction between Ergotamine and Lemborexant?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for excessive sedation and next-day drowsiness. Reduce the lemborexant dose if impairment occurs.

What other medicines interact with Ergotamine?

MediHelp also lists interactions of Ergotamine with, for example, Almotriptan, Atazanavir, Clarithromycin. The full list is on the Ergotamine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in